This MedLibrary.org supplementary page on Lornoxicam is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
|
|
Lornoxicam
|
|
| Systematic (IUPAC) name | |
| (3E)-6-chloro-3-[hydroxy-(pyridin-2-ylamino)methylidene]-2-methyl-1,1-dioxothieno[2,3-e]thiazin-4-one | |
| Identifiers | |
| CAS number | ? |
| ATC code | M01 |
| PubChem | |
| Chemical data | |
| Formula | C13H10ClN3O4S2 |
| Mol. mass | 371.8192 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Lornoxicam (chlortenoxicam) is a non-steroidal anti-inflammatory drug ([NSAID]) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties, is available in oral and parenteral formulations.
What is it used for:
- Inflammatory disease of the joints
- Osteoarthritis
- Pain following surgery
- Pain in the lower back and hip which travels down the back of the thigh into the leg (sciatica)
METABOLISM:
CYP2C9 has been shown to be the primary enzyme responsible for the biotransformation of the lornoxicam to its major metabolite, 5’-hydroxylornoxicam. Recently, it was reported that lornoxicam 5’-hydroxylation by the variant CYP2C9*3 and CYP2C9*13 was markedly reduced compared with wild type, both in vitro and in vivo. We suggest lornoxicam as a good Probe for CYP2C9 activity, both In Vitro and In Vivo.
Three of the most commonly employed substrate probes for determining CYP2C9 activity in crude human tissue fractions are (S)-warfarin (7-hydroxylation), tolbutamide (methylhydroxylation), and diclofenac (4_-hydroxylation). And the best in vivo probes for CYP2C9 activity are tolbutamide and flurbiprofen. Turnover of (S)-warfarin and tolbutamide by CYP2C9 is extremely slow. Conversely, diclofenac has the advantage that CYP2C9 catalyzes its[metabolism with a high turnover number, but is not a useful in vivo probe for the CYP2C9 enzyme.
We suggest lornoxicam as a good Probe for CYP2C9, both In Vitro and In Vivo. First, turnover of lornoxicam by CYP2C9 is much faster than (S)-warfarin and tolbutamide. So it is beneficial in allowing for facile, economical HPLC-UV assays to be employed for routine screening in vitro. Second, the lornoxicam poor metabolizer we found who is heterozygous for the CYP2C9*13 together with the CYP2C9*3, i.e. with the invalidated CYP2C9, has the lornoxicam half-life of about 105 h, indicating the specific biotransformation of the NSAID by CYP2C9.[1]
Mode of action:
Lornoxicam readily penetrates into synovial fluid. Lornoxicam synovial fluid: plasma AUC ratio is 0.5 after administration of 4mg twice daily.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||||||||||||||||||||
==Brand name LORNOXI 8mg LORNOXI 4mg
References
- ^ Zhang Yifan, Zhong Dafang*, Si Dayong, Guo Yingjie, Chen Xiaoyan, Zhou Hui. Lornoxicam pharmacokinetics in relation to cytochrome P450 2C9 genotype. The British Journal of Clinical Pharmacology. 2005 Jan;59(1):14-7. Times Cited: 10
- ^ Guo Yingjie, Zhang Yifan, Wang Ying, Chen Xiaoyan, Si Dayong, Zhong Dafang, Fawcett JP, Zhou Hui*. Role of CYP2C9 and its variants (CYP2C9*3 and CYP2C9*13) in the metabolism of lornoxicam in human. Drug Metab Dispos. 2005 Jun;33(6):749-53. Times Cited: 14
LORNOXI 8mg/4mg
Wikipedia content modification information:
- This page was last modified on 20 August 2008, at 13:34.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Lornoxicam".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.